Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05927350 · ClinicalTrials.gov registry record

Research Participation With Transgender and Gender-Diverse Youth

A clinical trial of Transgender Persons, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT05927350 is a study of Transgender Persons that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 250 participants, above the 223-participant average among 3 other Transgender Persons trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05927350, a study of Transgender Persons, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

Research has historically excluded the participation of transgender and gender-diverse people. The purpose of this research study is to find out about what goes into a transgender and gender-diverse youth's decision to participate in research. The results of this study will be used to improve access to research for transgender and gender-diverse youth and therefore, improve the representation of transgender and gender-diverse youth as research participants in research.

Conditions Studied

Interventions

  • OTHER Survey

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-01-29
Est. Completion 2026-06

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT05927350

The ClinicalTrials.gov registry entry for NCT05927350 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 223-participant average among 3 other Transgender Persons trials with a reported enrollment target (12% higher). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Transgender Persons appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.

NCT05927350 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05927350 about?

NCT05927350 is a clinical study titled "Research Participation With Transgender and Gender-Diverse Youth". Research has historically excluded the participation of transgender and gender-diverse people. The purpose of this research study is to find out about what goes into a transgender and gender-diverse youth's decision to participate in research. The results of this study will be used to improve access...

What is the current status of trial NCT05927350?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-01-29. Estimated completion is 2026-06.

What conditions does trial NCT05927350 study?

This clinical trial studies the following conditions: Transgender Persons.

What interventions are being tested in trial NCT05927350?

The interventions under investigation include: Survey (OTHER).

Who is sponsoring clinical trial NCT05927350?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05927350 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Transgender Persons

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.